跳到正文
原文
Endpoints News 生物医药· Elizabeth Cairns·· 11 天前AI 评分50

礼来在肥胖药物治疗睡眠呼吸暂停方面取得新进展

#AHA26: Lilly gets another sleep apnea win, this time with obesity pill

AI 导读

礼来计划寻求其肥胖药物在阻塞性睡眠呼吸暂停上的批准,基于 III 期试验的积极结果。

正文

Eli Lil­ly plans to seek ap­proval of its obe­si­ty med in ob­struc­tive sleep ap­nea af­ter a pos­i­tive Phase 3 tri­al, po­ten­tial­ly giv­ing it a new …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news